Stemline Therapeutics Reports Year-End 2012 Financial Results

[at noodls] – NEW YORK, April 1, 2013 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (Nasdaq:STML) (the Company), a clinical-stage biopharmaceutical company developing oncology therapeutics that target … more

View todays social media effects on STML

View the latest stocks trending across Twitter. Click to view dashboard

See who Stemline is hiring next, click here to view